OR7E130P

Across TCGA pan-cancer cohorts, OR7E130P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of OR7E130P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where OR7E130P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E130P is over-expressed in tumor, although a few such as LIHC and THCA show the opposite, repressed pattern.

UCEC, BRCA, and LUSC are the cancer types where OR7E130P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E130P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.099	.017	6	view →
BRCA	Female	All	+0.035	.025	4	view →
LUSC	All	All	+0.058	.002	2	view →
LIHC	Female	III,IV	−0.036	.043	1	view →
KIRC	Female	II,III,IV	+0.032	.040	1	view →
THCA	All	III,IV	−0.019	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

OR7E130P–UCEC

Open the UCEC breakdown →